A pilot study to assess feasibility of value based pricing in Cyprus through pharmacoeconomic modelling and assessment of its operational framework: sorafenib for second line renal cell cancer.

Petrou, Panagiotis; Talias, Michael A

Petrou, Panagiotis; Talias, Michael A.

Afiliação

Petrou P; HealthCare Management Program, Open University of Cyprus, 33 Giannou Kranidioti Avenue 2220, P.O BOX 12794, 2252 Nicosia, Cyprus.
Talias MA; HealthCare Management Program, Open University of Cyprus, 33 Giannou Kranidioti Avenue 2220, P.O BOX 12794, 2252 Nicosia, Cyprus.

Cost Eff Resour Alloc ; 12: 12, 2014.

Article em En | MEDLINE | ID: mdl-24910539

Palavras-chave

JEL 110; JEL 130; JEL 300; Markov Model; Pharmacoeconomic modelling; Sorafenib; Value based pricing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation Idioma: En Ano de publicação: 2014 Tipo de documento: Article